Noopept
About
About Noopept
Noopept is a synthetic dipeptide nootropic derived from piracetam with substantially greater potency and oral bioavailability. It is approved in Russia as a prescription nootropic for cognitive impairment and is used globally as a cognitive enhancer. Studies show improvements in memory, learning, and neuroplasticity markers. It is available as a research compound in the US.
Science
Mechanism of Action
Metabolized to cycloprolylglycine (a natural neuropeptide), it modulates AMPA receptors to enhance LTP and synaptic plasticity; also increases expression of BDNF and NGF in the hippocampus.
Dosing
Typical Protocol
10–30 mg oral or sublingual 1–2x daily; sublingual administration improves onset and bioavailability.
⚠ Protocol information is for educational purposes only. Dosing must be determined by a licensed physician based on individual health status and goals.
Regulatory
Legal Status in 2026
This compound occupies a regulatory grey area in 2026. It is neither explicitly FDA-approved nor clearly illegal for personal use, but it lacks formal clinical approval and may not be legally sold for human use in all contexts. Proceed with caution: source quality is variable, and regulatory status can change. Always consult a physician.
Evidence
Evidence Tier
Evidence primarily from animal studies, cell cultures, or small pilot human trials. Results are promising but have not yet been confirmed in large-scale human RCTs. Effects in humans may differ from animal models.
Find a Verified Provider
See which Vial-verified providers offer Noopept — with trust scores, legal credentials, and pricing transparency.